爱液视频

Hero

News & Events

爱液视频 in the News
BioCentury Article:听爱液视频: Attacking Tumors from Within

Fierce Biotech:

爱液视频 Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial

爱液视频 Therapeutics Selected to Present Targeted LTBR Agonist MST鈥�0312 in Late鈥態reaking Session at AACR Annual Meeting

爱液视频 Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

爱液视频 Therapeutics to Present Data on Targeted LTBR Agonist MST-0312 at Cancer Immunotherapy Keystone Symposia

爱液视频 Therapeutics Appoints Dr. Matthew Sleeman as Chief Scientific Officer

View All Press Releases